Celcuity (CELC) Research & Development (2016 - 2025)
Celcuity (CELC) posted Research & Development of $37.6 million for Q4 2025, up 7.79% on a QoQ basis from $34.9 million in Q3 2025, and up 12.44% year-over-year from $33.5 million in Q4 2024.
Celcuity (CELC) Research & Development (2016 - 2025) Analysis & Trends
Celcuity's Research & Development history runs 10 years deep, the most recent figure standing at $37.6 million for Q4 2025.
- Quarterly Research & Development rose 12.44% year-over-year to $37.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $145.0 million (up 39.15% YoY) and the FY2025 annual result came in at $145.0 million, up 39.15% from the prior year.
- Research & Development was $37.6 million for Q4 2025 at Celcuity, up from $34.9 million in the prior quarter.
- Across five years, Research & Development topped out at $40.2 million in Q2 2025 and bottomed at $2.2 million in Q1 2021.
- A 5-year average of $18.5 million and a median of $15.6 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2021 — Research & Development jumped 640.0% — and 2022, when it slumped 35.98%.
- Celcuity's Research & Development stood at $5.5 million in 2021, then jumped by 93.12% to $10.6 million in 2022, then surged by 70.51% to $18.1 million in 2023, then surged by 85.11% to $33.5 million in 2024, then gained by 12.44% to $37.6 million in 2025.
- Business Quant data shows CELC's Research & Development at $37.6 million in Q4 2025, $34.9 million in Q3 2025, and $40.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 37.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.64 Mn |
| Sep 30, 2025 | 34.92 Mn |
| Jun 30, 2025 | 40.22 Mn |
| Mar 31, 2025 | 32.23 Mn |
| Dec 31, 2024 | 33.47 Mn |
| Sep 30, 2024 | 27.59 Mn |
| Jun 30, 2024 | 22.50 Mn |
| Mar 31, 2024 | 20.65 Mn |
| Dec 31, 2023 | 18.08 Mn |
| Sep 30, 2023 | 17.49 Mn |
| Jun 30, 2023 | 13.75 Mn |
| Mar 31, 2023 | 11.28 Mn |
| Dec 31, 2022 | 10.60 Mn |
| Sep 30, 2022 | 9.62 Mn |
| Jun 30, 2022 | 8.37 Mn |
| Mar 31, 2022 | 6.70 Mn |
| Dec 31, 2021 | 5.49 Mn |
| Sep 30, 2021 | 4.96 Mn |
| Jun 30, 2021 | 13.07 Mn |
| Mar 31, 2021 | 2.24 Mn |